2.53
price down icon8.33%   -0.23
 
loading
Codexis Inc stock is traded at $2.53, with a volume of 689.54K. It is down -8.33% in the last 24 hours and down -38.29% over the past month. Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
See More
Previous Close:
$2.76
Open:
$2.74
24h Volume:
689.54K
Relative Volume:
0.88
Market Cap:
$209.58M
Revenue:
$70.14M
Net Income/Loss:
$-76.24M
P/E Ratio:
-2.2793
EPS:
-1.11
Net Cash Flow:
$-57.06M
1W Performance:
-7.33%
1M Performance:
-38.29%
6M Performance:
-8.99%
1Y Performance:
-25.15%
1-Day Range:
Value
$2.515
$2.7837
1-Week Range:
Value
$2.515
$2.845
52-Week Range:
Value
$2.47
$6.08

Codexis Inc Stock (CDXS) Company Profile

Name
Name
Codexis Inc
Name
Phone
650-421-8100
Name
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Name
Employee
188
Name
Twitter
@codexisinc
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
CDXS's Discussions on Twitter

Compare CDXS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CDXS
Codexis Inc
2.53 209.58M 70.14M -76.24M -57.06M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.92 129.14B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.61 74.41B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
581.21 35.31B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.75 31.30B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
254.57 27.35B 3.32B -860.46M -1.04B -8.32

Codexis Inc Stock (CDXS) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-19-24 Downgrade The Benchmark Company Buy → Hold
Jun-03-24 Resumed Jefferies Buy
May-30-24 Initiated Cantor Fitzgerald Overweight
Feb-29-24 Upgrade The Benchmark Company Hold → Buy
Nov-07-23 Downgrade The Benchmark Company Buy → Hold
Aug-07-23 Downgrade TD Cowen Outperform → Market Perform
May-09-23 Downgrade H.C. Wainwright Buy → Neutral
Mar-31-22 Resumed Piper Sandler Overweight
Mar-02-22 Resumed Cowen Outperform
Apr-12-21 Initiated Piper Sandler Overweight
Mar-01-21 Initiated Stifel Buy
Feb-26-21 Reiterated H.C. Wainwright Buy
Mar-10-20 Initiated The Benchmark Company Buy
Jan-17-19 Upgrade First Analysis Sec Neutral → Outperform
May-16-18 Initiated Stephens Overweight
Oct-13-17 Reiterated H.C. Wainwright Buy
May-31-17 Initiated Jefferies Buy
Jan-26-17 Downgrade First Analysis Sec Overweight → Equal-Weight
Jan-04-17 Upgrade Ladenburg Thalmann Neutral → Buy
Jan-06-16 Initiated H.C. Wainwright Buy
View All

Codexis Inc Stock (CDXS) Latest News

pulisher
Mar 10, 2025

Codexis sees $261,350 stock acquisition by Opaleye management By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Codexis sees $261,350 stock acquisition by Opaleye management - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Stocks of Codexis Inc (CDXS) are poised to climb above their peers - SETE News

Mar 10, 2025
pulisher
Mar 10, 2025

Major Shareholder Makes Bold Move with Codexis Stock Purchase! - TipRanks

Mar 10, 2025
pulisher
Mar 09, 2025

Codexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Advances - GuruFocus.com

Mar 09, 2025
pulisher
Mar 07, 2025

Codexis Announces New Employment Inducement Grants - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

Codexis grants equity to new hires under inducement plan - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

New Hires at Codexis Receive Significant Equity Compensation Package - StockTitan

Mar 07, 2025
pulisher
Mar 07, 2025

FY2025 EPS Estimates for Codexis Raised by Cantor Fitzgerald - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Codexis sees $172,273 stock purchase by Opaleye management - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Codexis sees $172,273 stock purchase by Opaleye management By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Things To Consider Before Buying Codexis Inc (NASDAQ: CDXS) - Stocks Register

Mar 06, 2025
pulisher
Mar 06, 2025

Codexis at TD Cowen Conference: Enzymatic Innovation in siRNA Manufacturing - Investing.com

Mar 06, 2025
pulisher
Mar 05, 2025

This trade activity should not be overlooked: Codexis Inc (CDXS) - SETE News

Mar 05, 2025
pulisher
Mar 05, 2025

Codexis stock touches 52-week low at $2.55 amid market challenges - Investing.com Australia

Mar 05, 2025
pulisher
Mar 03, 2025

Codexis Inc: Is CDXS Stock Worth Buying? - Stocks Register

Mar 03, 2025
pulisher
Mar 02, 2025

Investor Network: Codexis, Inc. to Host Earnings Call - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 02, 2025

5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io

Mar 02, 2025
pulisher
Mar 01, 2025

Codexis (NASDAQ:CDXS investor three-year losses grow to 84% as the stock sheds US$93m this past week - Simply Wall St

Mar 01, 2025
pulisher
Mar 01, 2025

When Will Codexis, Inc. (NASDAQ:CDXS) Become Profitable? - Yahoo Finance UK

Mar 01, 2025
pulisher
Feb 28, 2025

Codexis Inc (CDXS) Q4 2024 Earnings Call Highlights: Strategic P - GuruFocus.com

Feb 28, 2025
pulisher
Feb 28, 2025

Codexis (CDXS) Reports Q4 Loss, Misses Revenue Estimates - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Codexis, Inc. (NASDAQ:CDXS) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

Codexis shares tumble as Q4 results miss estimates, outlook disappoints - Investing.com India

Feb 28, 2025
pulisher
Feb 28, 2025

Codexis Inc (CDXS) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Revenue Growth ... - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

Codexis Reports 2024 Results, Eyes Growth in 2025 - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Codexis: Balancing Revenue Shortfalls and Strategic Advances Amid Cautious Optimism - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

Codexis Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Codexis Q4 2024 misses earnings, stock slips By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Codexis Q4 2024 misses earnings, stock slips - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Codexis: Q4 Earnings Snapshot - The Advocate

Feb 27, 2025
pulisher
Feb 27, 2025

Codexis shares tumble as Q4 results miss estimates, outlook disappoints By Investing.com - Investing.com Australia

Feb 27, 2025
pulisher
Feb 27, 2025

Codexis, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 25, 2025

Codexis Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView

Feb 25, 2025
pulisher
Feb 20, 2025

Specialty Enzymes Market to Expand at 7.5% CAGR, Reaching USD 10.7 Billion by 2032 | SNS Insider - GlobeNewswire Inc.

Feb 20, 2025
pulisher
Feb 20, 2025

Codexis announces the approval of equity grants for new employees - MSN

Feb 20, 2025
pulisher
Feb 19, 2025

Codexis (CDXS) to Release Quarterly Earnings on Wednesday - Defense World

Feb 19, 2025
pulisher
Feb 18, 2025

Codexis to Participate in TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 18, 2025
pulisher
Feb 18, 2025

Jordan Seigel - The Globe and Mail

Feb 18, 2025
pulisher
Feb 18, 2025

Exclusive: Codexis Unveils Future Roadmap at Major Healthcare Conference - StockTitan

Feb 18, 2025
pulisher
Feb 18, 2025

Baillie Gifford & Co. Sells 119,775 Shares of Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

Synthetic Biology Market Top Companies StudyBota Biosciences - openPR

Feb 18, 2025
pulisher
Feb 14, 2025

abrdn plc Reduces Stake in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Strategic Talent Investment: Codexis Awards 66.5K Shares in Employee Equity Package - StockTitan

Feb 14, 2025

Codexis Inc Stock (CDXS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):